Literature DB >> 11344308

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

A J Tipping1, T Pearson, N V Morgan, R A Gibson, L P Kuyt, C Havenga, E Gluckman, H Joenje, T de Ravel, S Jansen, C G Mathew.   

Abstract

Fanconi anemia (FA) is a rare, genetically heterogeneous autosomal recessive disorder associated with progressive aplastic anemia, congenital abnormalities, and cancer. FA has a very high incidence in the Afrikaner population of South Africa, possibly due to a founder effect. Previously we observed allelic association between polymorphic markers flanking the FA group A gene (FANCA) and disease chromosomes in Afrikaners. We genotyped 26 FA families with microsatellite and single nucleotide polymorphic markers and detected five FANCA haplotypes. Mutation scanning of the FANCA gene revealed association of these haplotypes with four different mutations. The most common was an intragenic deletion of exons 12-31, accounting for 60% of FA chromosomes in 46 unrelated Afrikaner FA patients, while two other mutations accounted for an additional 20%. Screening for these mutations in the European populations ancestral to the Afrikaners detected one patient from the Western Ruhr region of Germany who was heterozygous for the major deletion. The mutation was associated with the same unique FANCA haplotype as in Afrikaner patients. Genealogical investigation of 12 Afrikaner families with FA revealed that all were descended from a French Huguenot couple who arrived at the Cape on June 5, 1688, whereas mutation analysis showed that the carriers of the major mutation were descendants of this same couple. The molecular and genealogical evidence is consistent with transmission of the major mutation to Western Germany and the Cape near the end of the 17th century, confirming the existence of a founder effect for FA in South Africa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344308      PMCID: PMC33282          DOI: 10.1073/pnas.091402398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.

Authors:  J P de Winter; M A Rooimans; L van Der Weel; C G van Berkel; N Alon; L Bosnoyan-Collins; J de Groot; Y Zhi; Q Waisfisz; J C Pronk; F Arwert; C G Mathew; R J Scheper; M E Hoatlin; M Buchwald; H Joenje
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR.

Authors:  R G Roberts; A J Coffey; M Bobrow; D R Bentley
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

Review 3.  Medical genetics in South Africa.

Authors:  T Jenkins
Journal:  J Med Genet       Date:  1990-12       Impact factor: 6.318

4.  Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9.

Authors:  C A Strathdee; A M Duncan; M Buchwald
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

5.  A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones.

Authors:  J Riley; R Butler; D Ogilvie; R Finniear; D Jenner; S Powell; R Anand; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

Review 6.  Alu repeats and human disease.

Authors:  P L Deininger; M A Batzer
Journal:  Mol Genet Metab       Date:  1999-07       Impact factor: 4.797

7.  High frequency of large intragenic deletions in the Fanconi anemia group A gene.

Authors:  N V Morgan; A J Tipping; H Joenje; C G Mathew
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

8.  Isolation of a cDNA representing the Fanconi anemia complementation group E gene.

Authors:  J P de Winter; F Léveillé; C G van Berkel; M A Rooimans; L van Der Weel; J Steltenpool; I Demuth; N V Morgan; N Alon; L Bosnoyan-Collins; J Lightfoot; P A Leegwater; Q Waisfisz; K Komatsu; F Arwert; J C Pronk; C G Mathew; M Digweed; M Buchwald; H Joenje
Journal:  Am J Hum Genet       Date:  2000-09-19       Impact factor: 11.025

9.  The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners.

Authors:  M J Kotze; E Langenhoven; L Warnich; L du Plessis; A E Retief
Journal:  Ann Hum Genet       Date:  1991-05       Impact factor: 1.670

10.  Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.

Authors:  M Wijker; N V Morgan; S Herterich; C G van Berkel; A J Tipping; H J Gross; J J Gille; G Pals; M Savino; C Altay; S Mohan; I Dokal; J Cavenagh; J Marsh; M van Weel; J J Ortega; D Schuler; E Samochatova; M Karwacki; A N Bekassy; M Abecasis; W Ebell; M L Kwee; T de Ravel
Journal:  Eur J Hum Genet       Date:  1999-01       Impact factor: 4.246

View more
  29 in total

1.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Authors:  Maria Castella; Roser Pujol; Elsa Callén; Juan P Trujillo; José A Casado; Hans Gille; Francis P Lach; Arleen D Auerbach; Detlev Schindler; Javier Benítez; Beatriz Porto; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Luis Madero; Elena Cela; Cristina Beléndez; Cristina Díaz de Heredia; Teresa Olivé; José Sánchez de Toledo; Isabel Badell; Montserrat Torrent; Jesús Estella; Angeles Dasí; Antonia Rodríguez-Villa; Pedro Gómez; José Barbot; María Tapia; Antonio Molinés; Angela Figuera; Juan A Bueren; Jordi Surrallés
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 2.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

3.  Analysis of overlapping heterozygous novel submicroscopic CNVs and FANCA-VPS9D1 fusion transcripts in a Fanconi anemia patient.

Authors:  Daijing Nie; Panxiang Cao; Fang Wang; Jing Zhang; Mingyue Liu; Wei Zhang; Lili Liu; Huizheng Zhao; Wen Teng; Wenjun Tian; Xue Chen; Yang Zhang; Hua Nan; Zhijie Wei; Tong Wang; Hongxing Liu
Journal:  J Hum Genet       Date:  2019-06-26       Impact factor: 3.172

4.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

5.  Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.

Authors:  Elizabeth K Flynn; Aparna Kamat; Francis P Lach; Frank X Donovan; Danielle C Kimble; Narisu Narisu; Erica Sanborn; Farid Boulad; Stella M Davies; Alfred P Gillio; Richard E Harris; Margaret L MacMillan; John E Wagner; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

Review 6.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

7.  Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.

Authors:  Rencia van der Sluis
Journal:  Mol Genet Genomics       Date:  2018-06-14       Impact factor: 3.291

8.  Concerns regarding the potentially causal role of FANCA heterozygous variants in human primary ovarian insufficiency.

Authors:  Abdelkader Heddar; Micheline Misrahi
Journal:  Hum Genet       Date:  2020-11-05       Impact factor: 4.132

9.  Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.

Authors:  Candice Feben; Careni Spencer; Anneline Lochan; Nakita Laing; Karen Fieggen; Engela Honey; Tasha Wainstein; Amanda Krause
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 10.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.